Goldman Sachs’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$53.3M Sell
442,900
-109,600
-20% -$12.7M 0.01% 1532
2025
Q4
$58.2M Buy
552,500
+518,000
+1,501% +$48.6M 0.01% 1390
2025
Q3
$2.9M Sell
34,500
-313,800
-90% -$25.8M ﹤0.01% 4147
2025
Q2
$27.6M Buy
348,300
+298,300
+597% +$23.7M ﹤0.01% 1842
2025
Q1
$4.49M Buy
50,000
+5,500
+12% +$514K ﹤0.01% 3469
2024
Q4
$4.43M Sell
44,500
-397,500
-90% -$41M ﹤0.01% 3561
2024
Q3
$50.2M Buy
442,000
+386,800
+701% +$46M 0.01% 1237
2024
Q2
$6.83M Sell
55,200
-90,500
-62% -$11.7M ﹤0.01% 2869
2024
Q1
$19.2M Sell
145,700
-226,900
-61% -$28M ﹤0.01% 1872
2023
Q4
$40.6M Sell
372,600
-324,400
-47% -$33.7M 0.01% 1327
2023
Q3
$71.8M Sell
697,000
-493,100
-41% -$53.1M 0.02% 894
2023
Q2
$137M Buy
1,190,100
+1,054,400
+777% +$120M 0.03% 588
2023
Q1
$14.4M Sell
135,700
-9,600
-7% -$1.04M ﹤0.01% 2089
2022
Q4
$16.1M Sell
145,300
-498,100
-77% -$50.9M ﹤0.01% 2149
2022
Q3
$55.4M Sell
643,400
-211,400
-25% -$18.9M 0.01% 1046
2022
Q2
$77.9M Sell
854,800
-38,400
-4% -$3.4M 0.02% 842
2022
Q1
$73.3M Sell
893,200
-92,300
-9% -$7.28M 0.02% 979
2021
Q4
$75.5M Buy
985,500
+948,700
+2,578% +$75.6M 0.02% 1003
2021
Q3
$2.76M Buy
36,800
+25,100
+215% +$1.91M ﹤0.01% 3897
2021
Q2
$910K Sell
11,700
-161,220
-93% -$12M ﹤0.01% 4838
2021
Q1
$12.7M Buy
172,920
+33,641
+24% +$2.48M ﹤0.01% 2346
2020
Q4
$10.9M Sell
139,279
-451,793
-76% -$34.6M ﹤0.01% 2386
2020
Q3
$46.8M Buy
591,072
+354,329
+150% +$27.8M 0.01% 1057
2020
Q2
$17.5M Sell
236,743
-81,325
-26% -$6.12M 0.01% 1794
2020
Q1
$23.4M Sell
318,068
-50,514
-14% -$3.97M 0.01% 1400
2019
Q4
$32M Sell
368,582
-408,091
-53% -$33.5M 0.01% 1482
2019
Q3
$62.4M Buy
776,673
+240,935
+45% +$19.3M 0.02% 956
2019
Q2
$42.9M Sell
535,738
-127,436
-19% -$9.76M 0.01% 1242
2019
Q1
$52.6M Sell
663,174
-149,864
-18% -$11.2M 0.02% 1078
2018
Q4
$59.3M Buy
813,038
+31,335
+4% +$2.21M 0.02% 967
2018
Q3
$52.9M Sell
781,703
-464,579
-37% -$29.6M 0.01% 1179
2018
Q2
$72.2M Sell
1,246,282
-76,504
-6% -$4.32M 0.02% 960
2018
Q1
$68.8M Buy
1,322,786
+257,913
+24% +$13.9M 0.02% 1004
2017
Q4
$57.2M Sell
1,064,873
-203,312
-16% -$11.3M 0.01% 1191
2017
Q3
$77.5M Sell
1,268,185
-1,396,145
-52% -$84.6M 0.02% 970
2017
Q2
$163M Buy
2,664,330
+2,004,928
+304% +$122M 0.04% 501
2017
Q1
$40M Sell
659,402
-645,253
-49% -$39.1M 0.01% 1376
2016
Q4
$73.3M Buy
1,304,655
+615,909
+89% +$36M 0.02% 996
2016
Q3
$41M Sell
688,746
-124,712
-15% -$7.29M 0.01% 1359
2016
Q2
$44.7M Sell
813,458
-513,729
-39% -$27.3M 0.01% 1199
2016
Q1
$67M Sell
1,327,187
-1,975,585
-60% -$96.8M 0.02% 888
2015
Q4
$166M Buy
3,302,772
+99,036
+3% +$4.99M 0.05% 428
2015
Q3
$151M Buy
3,203,736
+779,922
+32% +$41.4M 0.05% 426
2015
Q2
$132M Buy
2,423,814
+1,150,704
+90% +$64.5M 0.04% 513
2015
Q1
$69.8M Buy
1,273,110
+45,378
+4% +$2.57M 0.02% 848
2014
Q4
$66.5M Sell
1,227,732
-323,098
-21% -$18M 0.02% 905
2014
Q3
$87.7M Sell
1,550,830
-344,059
-18% -$19.3M 0.03% 699
2014
Q2
$105M Sell
1,894,889
-1,206,877
-39% -$65.8M 0.03% 646
2014
Q1
$168M Buy
3,101,766
+917,944
+42% +$47.5M 0.06% 383
2013
Q4
$104M Sell
2,183,822
-861,037
-28% -$39.4M 0.03% 615
2013
Q3
$138M Sell
3,044,859
-1,743,348
-36% -$79.6M 0.05% 427
2013
Q2
$212M Buy
+4,788,207
New +$214M 0.08% 249

Other funds holding MRK

Goldman Sachs's MRK Position: Q1 2026 in Review

Goldman Sachs increased its Merck (MRK) stake by 4.1% in Q1 2026, buying an estimated $90.6M and bringing the position to 20,133,379 shares worth $2.42B. The position accounts for 0.28% of the portfolio, ranked #50.

Goldman Sachs first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Goldman Sachs held 20,133,379 shares of Merck worth $2.42B as of Q1 2026.
  • Goldman Sachs bought 784,661 Merck shares in Q1 2026, an estimated $90.6M.
  • Merck made up 0.28% of Goldman Sachs's portfolio in Q1 2026, its #50 holding.
  • Goldman Sachs first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • 3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.